Clinical Pharmacological Approach To The Drug Treatment Of Arthritis, Arthralgia And Back Pain Syndromes
DOI:
https://doi.org/10.62480/tjms.2025.vol42.pp60-62Keywords:
children, etanercept, juvenile arthritis, adalimumabAbstract
The article is devoted to one of the most common rheumatic diseases — juvenile arthritis (JA). The main issues of epidemiology, classification, pathogenesis are considered, in more detail — the clinical picture of different variants of the course of JA, diagnostics and differential diagnosis. The treatment section describes the drugs used in JA, and presents an algorithm for differentiated treatment of the disease. Approaches to biological therapy, conditions for prescribing and management of patients receiving genetically engineered biological drugs are described separately.
References
Bijlsma JWJ, Berenbaum F, Lafeber FPJG. Osteoarthritis: an update with relevance for clinical
practice. Lancet. 2011;377(9783):2115-2126.
Firestein GS, McInnes IB. Immunopathogenesis of rheumatoid arthritis. Immunity. 2017;46(2):183-
McAlindon TE, Bannuru RR, Sullivan MC, et al. OARSI guidelines for the non-surgical
management of knee osteoarthritis. Osteoarthritis Cartilage. 2014;22(3):363-388.
Hochberg MC, Altman RD, April KT, et al. American College of Rheumatology 2012
recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of
the hand, hip, and knee. Arthritis Care Res (Hoboken). 2012;64(4):465-474.
Kolasinski SL, Neogi T, Hochberg MC, et al. 2019 American College of Rheumatology/Arthritis
Foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis
Rheumatol. 2020;72(2):220-233.
Cohen SP, Vase L, Hooten WM. Chronic pain: an update on burden, best practices, and new
advances. Lancet. 2021;397(10289):2082-2097
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
User Rights
Under the Creative Commons Attribution-NonCommercial 4.0 International (CC-BY-NC), the author (s) and users are free to share (copy, distribute and transmit the contribution).
Rights of Authors
Authors retain the following rights:
1. Copyright and other proprietary rights relating to the article, such as patent rights,
2. the right to use the substance of the article in future works, including lectures and books,
3. the right to reproduce the article for own purposes, provided the copies are not offered for sale,
4. the right to self-archive the article.
